Cancer Research UK
Drug Development Project
Rolling deadline
Last updated:
No deadline is on file for this call. Check Cancer Research UK's own call page for the current round's status before you plan around it.
The Drug Development Project channels scientific, clinical and trial management resources from Cancer Research UK's Centre for Drug Development into preclinical through early-phase (Phase 1/early Phase 2) clinical development of novel cancer agents. It is open to individual applicants at academic institutions or pharma/biotech companies, in the UK or internationally, and runs as a direct partnership rather than a traditional grant. Applications are accepted continuously, starting with an informal confidential discussion before formal review.
Details
| Funder | Cancer Research UK |
| Consortium | No - individual applicant based at academic institution or pharma/biotech company, project run in partnership with CRUK's Centre for Drug Development |
| Application | Informal confidential discussion, then formal review by New Agents Committee (up to 4 times per year) |
| TRL | 3-6 |
| Frequency | Continuous |
| Eligible countries | GB |
Eligibility & scope
Supports preclinical development through early phase (Phase 1/early Phase 2) clinical trials of novel cancer agents; not external grant funding but scientific, clinical and trial management resources provided by CRUK's Centre for Drug Development. Open to academic institutions and pharma/biotech companies (UK or international); requires prior confidential discussion and eligibility check.
Who Should Apply
- •Researchers or teams with a novel cancer agent ready for preclinical to early clinical development
- •Applicants based at academic institutions, UK or international
- •Applicants based at pharma or biotech companies, UK or international
- •Projects at TRL 3-6, targeting Phase 1 or early Phase 2 trials
- •Individual applicants who do not need a pre-formed consortium
Key Dates
- •Rolling deadline; applications accepted continuously
- •Two-stage process: informal confidential discussion first, then formal review by the New Agents Committee (up to 4 times per year)
Tips for Applicants
- ✓Request the informal confidential discussion early, it determines eligibility before you commit to a formal submission.
- ✓Frame the project around TRL 3-6 milestones; the New Agents Committee assesses readiness for preclinical-to-clinical progression specifically.
- ✓Since this provides in-kind resources rather than a grant, emphasize what CRUK's Centre for Drug Development capabilities (not your own budget) can add to the project.
Frequently Asked Questions
How much funding does the CRUK Drug Development Project provide?
It is not a cash grant; instead CRUK's Centre for Drug Development provides scientific, clinical and trial management resources to progress the project.
Who can apply for the CRUK Drug Development Project?
Individual applicants (no consortium required) based at an academic institution or a pharma/biotech company, either in the UK or internationally.
What stage of drug development does this scheme support?
It covers preclinical development through early phase clinical trials, corresponding to TRL 3-6, up to Phase 1 or early Phase 2.
When is the deadline for the CRUK Drug Development Project?
There is no fixed deadline; applications are accepted on a rolling basis and reviewed by the New Agents Committee up to four times a year.
Do I need a consortium to apply?
No, this call does not require a consortium; the project runs as a partnership between the individual applicant and CRUK's Centre for Drug Development.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
CDD Scouting Programme
KWFUp to €2 million per projectTherapeutic Catalyst - Early Therapy Award
Cancer Research UKDeadline: 25 Sept 2026Up to £350kTherapeutic Catalyst
Cancer Research UKDeadline: 25 Sept 2026Up to £250k (Target Award) or up to £350k (Early Therapy Award)Childhood Cancer Therapeutic Catalyst
Cancer Research UKUp to £250kDiscovery Programme Award
Cancer Research UKDeadline: 29 Sept 2026Up to £2.5m
Browse Related
Could Drug Development Project be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →